1. Management of Phenibut Use Disorder and Withdrawal in a Geriatric Patient
- Author
-
Ethan Wainblat, Jeremy Weleff, and Akhil Anand
- Subjects
Male ,Benzodiazepines ,Psychiatry and Mental health ,Substance-Related Disorders ,Humans ,Hypnotics and Sedatives ,Geriatrics and Gerontology ,gamma-Aminobutyric Acid ,Aged - Abstract
Phenibut is a misused substance which has shown an increase in use over the past decade. Marketed as a "dietary supplement," it is not approved in the United States for use and is not regulated by the Food and Drug Administration. The substance, however, is readily available for purchase through online markets. It has a similar drug profile as alcohol, gabapentin and benzodiazepines. Clinical effects of this drug include physiologic dependence, euphoria, anxiolysis, antispasticity, sedation, and possible nootropic properties. While there are emerging new cases of managing phenibut withdrawal, no cases currently feature phenibut addiction and withdrawal management in the geriatric population. Here we discuss such a case of phenibut addiction and withdrawal in a 68-year-old male who initially began misusing phenibut to alleviate anxiety and insomnia precipitated by worsening affective disorder, sedative, hypnotic, or anxiolytic use disorder, and alcohol use disorder.
- Published
- 2023
- Full Text
- View/download PDF